ZKZeynep Karakoy

Zeynep Karakoy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zeynep Karakoy has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeting vasopressin signaling in sepsis: Effects of tolvaptan on inflammation and aquaporin dysregulation

    by Zeynep Karakoy Kaya, Alperen Canpolat, Seydanur Avci, Betul Kavas, Erdem Toktay, Zafer Bayraktutan, Zekai Halici, Elif Cadirci

  • Güncel Farmakoterapi ve Biyokimya Current Pharmacotherapy and Biochemistry

    by Alperen Canpolat, Ayşe Bozkurt, Ayşegül Tavacı Özçelik, Betül Sena Uyanık, Cihad Özçelik, Eda Yılmaz, Elif Çadırcı, Fatma Betül Yoladı, Hamza Halıcı, Hilal Kaya, et al.

    Türkiyenin E-kitap portalı Libraryturk.com aracılığıyla Güncel Farmakoterapi ve Biyokimya Current Pharmacotherapy and Biochemistry adlı kitaba erişeblirsiniz.

  • Open Access

    Investigation of maresin 1 and possible associated intracellular pathways in nasal polyp pathophysiology

    by Zulkuf Kaya, Vahit Mutlu, Zekai Halici, Zeynep Karakoy Kaya, Aysegul Tavaci Ozcelik, Esma Topatan, Cihad Ozcelik

  • Effect of fluvoxamine on the pharmacokinetics of paracetamol in mice

    by Zeynep Karaköy

    Introduction: Paracetamol is one of the most widely used analgesic and antipyretic drugs in the world. Fluvoxamine is a SSRI drug used in the treatment of depression. Fluvoxamine and paracetamol can be used simultaneously in treatment. In the combined use of drugs, drug-drug interactions may occur at the point of absorption, distribution, metabolism and excretion. The aim of this study was to determine the effect of low and high dose fluvoxamine administration on the pharmacokinetics of paracetamol in mice. Materials and Methods: In this study, 96 male Swiss Albino mice were used. Mice were divided into three groups with equal numbers (n=30). Paracetamol (700 mg/kg) was administered to the first group, paracetamol+low-dose (30 mg/kg) fluvoxamine to the second group, and paracetamol+high-dose (150 mg/kg) fluvoxamine to the third group. Plasma concentrations of paracetamol were assayed using HPLC and pharmacokinetic parameters were calculated by noncompartmental analysis. Results: After a single administration of paracetamol, t1/2ʎz, EAA and Cdoruk were 2.99 h, 880.72 h*μg/mL, and 486.74 μg/mL, respectively. Low and high dose fluvoxamine administration resulted in an increase in EAA 32% and 61%, and Cdoruk 15% and 27% of paracetamol, respectively. Conclusions: As a result, low and high dose fluvoxamine administration increased the plasma concentration of paracetamol in mice. This increase in the concentration of paracetamol, the effect of which is dose dependent, may lead to an increase in the therapeutic effect. However, further research is needed to determine the safety and mechanism of interaction following the concomitant use of paracetamol and fluvoxamine. Keywords: Pharmacokinetics, fluvoxamine, paracetamol

  • Open Access

    Understanding the relationship between lung GABAA receptors and aquaporin-1: a new therapeutic approach for acute lung injury

    by Hamza Halici, Zeynep Karakoy, Elif Cadirci, Zekai Halici, Bengul Ozdemir, Erdem Toktay

    This study aimed to investigate the effects of the GABAA receptor and the potential relationship between GABA/ GABAA receptor signalling and aquaporin-1 in

  • Open Access

    Detorsion is not innocent: pirfenidone prevents contralateral ovarian damage following ovarian torsion

    by Hamza Halici, Zeynep Karakoy, Emir Enis Yurdgulu, Yusuf Anil Ay, Elif Cadirci, Erdem Toktay, Betul Kavas

    Ovarian torsion is a gynecological emergency caused by rotation of the vascular pedicle, leading to ischemia, necrosis, and potential fertility loss. Management remains controversial, particularly regarding oophorectomy versus ovarian preservation. Detorsed ovaries continue cytokine secretion, impairing contralateral ovarian function, and no protective therapy currently exists. This study aimed to compare oophorectomy and detorsion strategies and to determine whether post-detorsion long-term pirfenidone therapy preserves ovarian function, thereby providing experimental resolution to the clinically pivotal “save or sacrifice” dilemma. Forty female rats were divided into five groups: Healthy, IR, IR + OVX, IR + Pirfenidone 50 mg/kg, and IR + Pirfenidone 100 mg/kg. Ischemia was induced in the left ovary of IR groups; in IR + OVX, the ovary was excised at 3 h, while in other groups, ovaries were reperfused. Treatments continued for 30 days. Ovarian tissues and blood were analyzed histopathologically, biochemically, and molecularly. Ovarian ischemia–reperfusion induced a persistent inflammatory and profibrotic response not only in the ischemic ovary but also in the contralateral ovary, leading to reduced estrogen levels and marked histopathological damage. Importantly, detorsion alone did not prevent contralateral injury, whereas oophorectomy attenuated molecular alterations. Post-detorsion pirfenidone therapy dose-dependently restored estrogen production, suppressed inflammasome activation (IL-1β, NLRP3, caspase-1) and fibrotic signaling (SMAD2, SMAD3, TGF-β1), and preserved normal follicular architecture in both ovaries. These findings demonstrate that the detorsed ovary remains a biologically active source of injury and identify pirfenidone as a potential adjunct therapy capable of protecting ovarian function after torsion.


  • Low-dose Bee Venom as a Potential Therapeutic Agent Against Human Chronic Myeloid Leukaemia Cells

    by Hamza Halici, Harun Un, Saffet Celik, Zeynep Karakoy, Zafer Bayraktutan, Can Ozlu, Elif Cadirci, Zekai Halici, Alptug Atila, Filiz Mercantepe

    Bee venom is secreted by a gland in the abdominal cavity of bees. The venom, especially that of honeybees, contains certain enzymes and peptides that, when administered in high doses, are effective against various diseases. Peptides such as melittin and phospholipase A2 can target various cancer cells. In this study, we investigated the antiproliferative effects of administering low-dose bee venom in K-562 chronic myeloid leukaemia cells. Our proteomic study revealed regional variation of the content of bee venom and high levels of melittin, apamin and secapin, as well as phospholipase A2 and hyaluronidase. In addition, eight new, previously unidentified proteins were identified. The effects of bee venom on cell viability and drug–cell interaction were investigated at 24, 48 and 72 h. According to the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) results, the bee venom decreased K-562 cell viability dose-dependently at all time points. Cell viability decreased 48 and 72 h after bee venom administration but increased in the control group left untreated for 72 h. The inhibition percentages for the highest bee venom concentration (0.4 µM) at 24, 48 and 72 h were 55%, 80% and 92%, respectively. The cell–drug interactions indicated that the cell surfaces, which were smooth and clear before drug application, gradually deteriorated and started to shrink after the application. In conclusion, at increasing doses, bee venom was found to have a strong antiproliferative effect in K-562 chronic myeloid leukaemia cell lines.


  • The Effect of Inhaled Ozone Therapy in Two-Hit Rat Model of Lipopolysaccharides-Induced Acute Lung Injury and Bleomycin-Induced Pulmonary Fibrosis

    by Mine Celik, Mehmet Koca, Zekai Halici, Taha Tavaci, Hamza Halici, Mustafa Ozkaraca, Zeynep Karakoy, Zafer Bayraktutan

    Considering the limited treatment options for acute lung injury (ALI) and pulmonary fibrosis (PF), ozone treatment may be promising as a new immunological agent with its ability to modulate cytokines and interferons. We aimed to investigate the effects of inhaled ozone therapy on both ALI and PF in rat models. A total of 48 albino Wistar male rats were included in the study. Lipopolysaccharide (LPS) was used to induce the ALI model, and bleomycin was used for the PF model. The effects of inhaled ozone (O3) were investigated using the ELISA method. Hematoxylin&eosin staining, Masson’s trichrome staining, and immunohistochemical methods were used for histopathological evaluation. The Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), and Nuclear Factor kappa B subunit p65 (NF-κB p65) levels in the ALI + 0.08 ppm O3, ALI + 0.12 ppm O3, PF + 0.08 ppm O3, and PF + 0.12 ppm O3 groups statistically decreased to the same extent and approached the levels of control animals. It was observed that IL-1β, IL-6, TNF-α, and NF-κB p65 levels in lung tissues were significantly and dose-dependently decreased compared to the untreated PF and ALI groups, respectively. While fibrosis was severe in the PF + 0.08 ppm O3 group, it decreased to more moderate levels in the PF + 0.12 ppm O3 group. The cytokine levels confirmed that inhaled ozone protected the lungs from both ALI and the development of PF.


  • Novel therapeutic approaches targeting 5-HT7 receptors outside the central nervous system

    by Melis Kilic, Zeynep Karakoy, Hamza Halici, Elif Cadirci, Zekai Halici

    Serotonin (5-HT) is a neurotransmitter found throughout the human body that regulates many physiological events arising from the brain and central nervous system (CNS), such as sleep and appetite. However, it has many other functions in systems outside. In addition to the routine expression of 5-HT7 receptors in CNS regions, such as the pituitary gland, spinal cord, and hippocampus, many studies have reported the expression of these receptors in pathological conditions outside. The role of 5-HT7 receptors outside the CNS has been attracting increased attention in recent years. This review highlights the fact that 5-HT7 receptors are associated with diseases and systems beyond the CNS increasing or decreasing in response to cellular changes. Clinical, basic, in vivo and in vitro studies to date are described, but more research is needed to better understand the role of 5-HT7 receptors outside the CNS.

  • Avanafil Mitigates Testicular Ischemia/Reperfusion Injury via NLRP3 Pathway Modulation in Rats

    by Muhammet Celik, Pelin Aydin, Maide Sena Civelek, Nurullah Akgun, Zeynep Karakoy, Cihad Ozcelik, Gulcin Tanriverdiyeva, Erdem Toktay

    Objective: In our study, the effectiveness of avanafil, a second-generation phosphodiesterase-5 (PDE5) inhibitor, on testicular torsion (TT) related ischemia/reperfusion injury via NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3), which triggers inflammatory response, are studied molecularly, biochemically and histopathologically. Material and Method: This study was performed on 24 male Wistar albino rats randomized into four groups. Testicular ischemia/reperfusion (I/R) model was created for groups 2, 3 and 4. Groups 3 and 4, respectively, were administered a dose of 5 and 10 mg/kg avanafil before reperfusion by gavage. The testicles which were left in ischemia for two hours, were detorsioned for four hours. All animals were sacrificed after reperfusion. Testicular tissues were examined molecularly, biochemically and histopathologically. Results: The NLRP3, Interleukin-1β (IL-1β) and Tumor Necrosis alpha (TNF-α) mRNA expression levels were observed to be significantly increased in the I/R group compared to the healthy group (p < 0.001). After both doses of avanafil, NLRP3, IL-1β and TNF-α mRNA expression levels, which increased as a result of I/R, decreased in both avanafil groups. (p < 0.001). The greatest decrease was seen at the dose of 10 mg/kg (p < 0.001). Increased Malondialdehyde (MDA) levels due to I/R were statistically significantly decreased in both doses of avanafil (p < 0.001). Decreased Superoxide Dismutase (SOD) levels due to I/R damage increased statistically significantly in both doses of avanafil (p < 0.001). Conclusion: It was found that avanafil can reduce the damage caused by testicular I/R and that it will find new applications in the future with the support of advanced experimental and clinical studies. Graphical Abstract